U.S. Pot Earnings Shine as Canada Struggles: Cannabis Weekly
- Yet a valuation differential persists due to exchange rules
- Listings on U.S. exchanges would change that, strategist says
This article is for subscribers only.
The top U.S. cannabis companies are notably outperforming their struggling Canadian counterparts, yet valuations are still held back by their inability to list on the big American exchanges.
The divergence was well illustrated by two large companies that reported earnings Thursday night.